1. Home
  2. FC vs CATX Comparison

FC vs CATX Comparison

Compare FC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Covey Company

FC

Franklin Covey Company

HOLD

Current Price

$16.14

Market Cap

193.2M

ML Signal

HOLD

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$2.62

Market Cap

162.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FC
CATX
Founded
1983
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
162.8M
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
FC
CATX
Price
$16.14
$2.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$24.50
$11.56
AVG Volume (30 Days)
151.5K
1.9M
Earning Date
01-07-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$267,067,000.00
$1,075,000.00
Revenue This Year
$3.17
N/A
Revenue Next Year
$4.00
N/A
P/E Ratio
$70.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.04
$1.60
52 Week High
$39.22
$5.39

Technical Indicators

Market Signals
Indicator
FC
CATX
Relative Strength Index (RSI) 50.15 55.44
Support Level $15.68 $2.07
Resistance Level $17.02 $2.89
Average True Range (ATR) 0.62 0.18
MACD 0.19 0.09
Stochastic Oscillator 63.60 67.86

Price Performance

Historical Comparison
FC
CATX

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: